Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach.

Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, Avnstrøm S, Langholz E, O'Morain C, Lynge E, Munkholm P.

Gut. 2010 Dec;59(12):1652-61. doi: 10.1136/gut.2010.220160.

PMID:
21071584
2.

Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment.

Elkjaer M, Burisch J, Avnstrøm S, Lynge E, Munkholm P.

Eur J Gastroenterol Hepatol. 2010 Jun;22(6):695-704. doi: 10.1097/MEG.0b013e32832e0a18.

PMID:
19543101
5.

Challenges in the design of a Home Telemanagement trial for patients with ulcerative colitis.

Cross RK, Finkelstein J.

Clin Trials. 2009 Dec;6(6):649-57. doi: 10.1177/1740774509346978. Epub 2009 Oct 12.

PMID:
19822631
6.

"Take your medicine": nonadherence issues in patients with ulcerative colitis.

Turnbough L, Wilson L.

Gastroenterol Nurs. 2007 May-Jun;30(3):212-7; quiz 218-9. Review.

PMID:
17568260
7.

eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis.

Pedersen N, Thielsen P, Martinsen L, Bennedsen M, Haaber A, Langholz E, Végh Z, Duricova D, Jess T, Bell S, Burisch J, Munkholm P.

Inflamm Bowel Dis. 2014 Dec;20(12):2276-85. doi: 10.1097/MIB.0000000000000199.

PMID:
25248002
8.
9.

Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial.

Robinson A, Thompson DG, Wilkin D, Roberts C; Northwest Gastrointestinal Research Group.

Lancet. 2001 Sep 22;358(9286):976-81.

PMID:
11583752
10.

Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine.

Munkholm P, Michetti P, Probert CS, Elkjaer M, Marteau P.

Eur J Gastroenterol Hepatol. 2010 Aug;22(8):912-6. Review.

PMID:
20665988
11.

Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis.

Oxelmark L, Hillerås P, Dignass A, Mössner J, Schreiber S, Kruis W, Löfberg R.

Scand J Gastroenterol. 2007 Mar;42(3):406-7. No abstract available.

PMID:
17354122
12.

Systematic review: adherence issues in the treatment of ulcerative colitis.

Kane SV.

Aliment Pharmacol Ther. 2006 Mar 1;23(5):577-85. Review.

13.

Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.

Dignass AU, Bokemeyer B, Adamek H, Mross M, Vinter-Jensen L, Börner N, Silvennoinen J, Tan G, Pool MO, Stijnen T, Dietel P, Klugmann T, Vermeire S, Bhatt A, Veerman H.

Clin Gastroenterol Hepatol. 2009 Jul;7(7):762-9. doi: 10.1016/j.cgh.2009.04.004. Epub 2009 Apr 16.

PMID:
19375519
14.

Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being.

Bregenzer N, Lange A, Fürst A, Gross V, Schölmerich J, Andus T.

Z Gastroenterol. 2005 Apr;43(4):367-71.

PMID:
15830302
15.

Internet-based home monitoring and education of children with asthma is comparable to ideal office-based care: results of a 1-year asthma in-home monitoring trial.

Chan DS, Callahan CW, Hatch-Pigott VB, Lawless A, Proffitt HL, Manning NE, Schweikert M, Malone FJ.

Pediatrics. 2007 Mar;119(3):569-78.

PMID:
17332210
16.

Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.

Higgins PD, Rubin DT, Kaulback K, Schoenfield PS, Kane SV.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):247-57. doi: 10.1111/j.1365-2036.2008.03865.x. Epub 2008 Oct 7. Review.

17.

Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU).

Fernández-Bañares F, Hinojosa J, Sánchez-Lombraña JL, Navarro E, Martínez-Salmerón JF, García-Pugés A, González-Huix F, Riera J, González-Lara V, Domínguez-Abascal F, Giné JJ, Moles J, Gomollón F, Gassull MA.

Am J Gastroenterol. 1999 Feb;94(2):427-33.

PMID:
10022641
18.

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.

Kane S, Huo D, Aikens J, Hanauer S.

Am J Med. 2003 Jan;114(1):39-43.

PMID:
12543288
19.

[Analysis of total cost of treatment of patients with inflammatory bowel diseases].

Lazebnik LB, Parfenov AI, Guseĭnzade MG, Kniazev OV, Efremov LI.

Eksp Klin Gastroenterol. 2011;(5):3-7. Russian.

PMID:
21919238
20.

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.

Kane SV, Cohen RD, Aikens JE, Hanauer SB.

Am J Gastroenterol. 2001 Oct;96(10):2929-33.

Supplemental Content

Support Center